Q32 Bio (QTTB) Current Assets (2017 - 2026)
Q32 Bio (QTTB) posted quarterly Current Assets of $57.2 million for Q1 2026, down 16.65% year-over-year from $68.6 million in Q1 2025, and up 3.91% quarter-over-quarter from $55.0 million in Q4 2025.
Q32 Bio (QTTB) Current Assets (2017 - 2026) Analysis & Trends
Q32 Bio's Current Assets history runs 10 years deep, the most recent figure standing at $57.2 million for Q1 2026.
- In Q1 2026, Current Assets fell 16.65% year-over-year to $57.2 million; the TTM figure through Mar 2026 stood at $57.2 million (down 16.65% YoY), while the FY2025 annual figure was $55.0 million, down 32.77% from the prior year.
- Current Assets for Q1 2026 stood at $57.2 million, up from $55.0 million in the prior quarter.
- The five-year high for Current Assets was $262.4 million in Q1 2022, with the low at $28.7 million in Q4 2023.
- The 5-year median for Current Assets is $106.6 million (2023), against an average of $119.5 million.
- The sharpest annual moves came in 2023 and 2024: Current Assets tumbled 84.14% in 2023, then surged 185.13% in 2024.
- Q32 Bio's Current Assets stood at $181.0 million in 2022, then sank by 84.14% to $28.7 million in 2023, then soared by 185.13% to $81.9 million in 2024, then sank by 32.77% to $55.0 million in 2025, then rose by 3.91% to $57.2 million in 2026.
- Business Quant data shows QTTB's Current Assets at $57.2 million in Q1 2026, $55.0 million in Q4 2025, and $50.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - | 109.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 109.65 Mn |
| Mar 31, 2026 | 57.20 Mn |
| Dec 31, 2025 | 55.05 Mn |
| Sep 30, 2025 | 50.81 Mn |
| Jun 30, 2025 | 58.32 Mn |
| Mar 31, 2025 | 68.63 Mn |
| Dec 31, 2024 | 81.88 Mn |
| Sep 30, 2024 | 93.90 Mn |
| Jun 30, 2024 | 111.62 Mn |
| Mar 31, 2024 | 138.04 Mn |
| Dec 31, 2023 | 28.72 Mn |
| Sep 30, 2023 | 106.64 Mn |
| Jun 30, 2023 | 131.34 Mn |
| Mar 31, 2023 | 153.58 Mn |
| Dec 31, 2022 | 181.02 Mn |
| Sep 30, 2022 | 213.20 Mn |
| Jun 30, 2022 | 238.44 Mn |
| Mar 31, 2022 | 262.45 Mn |
| Dec 31, 2021 | 191.91 Mn |
| Sep 30, 2021 | 191.82 Mn |